Goldman Sachs Assumes Madrigal Pharmaceuticals (MDGL) at Buy
(Updated - September 24, 2026 5:37 AM EDT)
Goldman Sachs analyst Andrea Newkirk assumes coverage on Madrigal Pharmaceuticals (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Goldman Sachs analyst Andrea Newkirk assumes coverage on Madrigal Pharmaceuticals (NASDAQ ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

